date:Aug 09, 2012
tain performance in athletes (rather than normal consumers) during endurance exercise.
Cohen said that, on behalf of the BMJ, three Oxford University academics assessed the evidence behind Lucozadabased upon 106 studies conducted between 1971 and 2012, sinceGSK was the only firm to reply to a request for full links to studies (other major firms did not supply full bibliographies).
An accompanying analysis of the studies found that the quality of the evidence was so poor that it was impossible